EBIT at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
Plus components not separately reported this period.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's EBIT?
- Protagonist Therapeutics (PTGX) reported EBIT of -$3.65M in Q1 2026.
- How has Protagonist Therapeutics's EBIT changed year-over-year?
- Protagonist Therapeutics's EBIT increased by 81.1% year-over-year, from -$19.31M to -$3.65M.
- What is the long-term trend for Protagonist Therapeutics's EBIT?
- Over 3 years (2021 to 2025), Protagonist Therapeutics's EBIT has grown at a 7.9% compound annual growth rate (CAGR), from -$125.85M to -$158.13M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.